 Vesna Todorovic
Concepts (260)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anesthesia, General | 12 | 2021 | 105 | 3.190 |
Why?
| | Calcium Channels, T-Type | 10 | 2017 | 106 | 3.080 |
Why?
| | Isoflurane | 6 | 2021 | 39 | 2.470 |
Why?
| | Neurotoxicity Syndromes | 7 | 2017 | 35 | 1.740 |
Why?
| | Brain | 18 | 2022 | 2782 | 1.700 |
Why?
| | Anesthetics, General | 5 | 2021 | 13 | 1.590 |
Why?
| | Anesthetics | 5 | 2017 | 93 | 1.530 |
Why?
| | Calcium Channel Blockers | 5 | 2015 | 171 | 1.320 |
Why?
| | Sensory Receptor Cells | 5 | 2014 | 101 | 1.310 |
Why?
| | Anesthetics, Inhalation | 4 | 2015 | 45 | 1.270 |
Why?
| | Neuralgia | 5 | 2017 | 139 | 1.110 |
Why?
| | Hippocampus | 5 | 2018 | 920 | 1.070 |
Why?
| | Child Development | 3 | 2018 | 471 | 1.050 |
Why?
| | Presynaptic Terminals | 3 | 2015 | 91 | 1.020 |
Why?
| | Analgesics | 3 | 2014 | 219 | 0.980 |
Why?
| | Diabetic Neuropathies | 3 | 2014 | 93 | 0.880 |
Why?
| | Ganglia, Spinal | 5 | 2017 | 83 | 0.840 |
Why?
| | Hypnotics and Sedatives | 4 | 2017 | 209 | 0.760 |
Why?
| | Neurons | 6 | 2016 | 1603 | 0.740 |
Why?
| | Rats, Sprague-Dawley | 16 | 2018 | 2494 | 0.720 |
Why?
| | Neuroprotection | 1 | 2021 | 43 | 0.710 |
Why?
| | Animals | 42 | 2022 | 37309 | 0.710 |
Why?
| | Hyperalgesia | 4 | 2017 | 127 | 0.710 |
Why?
| | Anesthesia, Inhalation | 2 | 2015 | 13 | 0.700 |
Why?
| | Pain | 3 | 2017 | 775 | 0.700 |
Why?
| | Rats | 21 | 2018 | 5594 | 0.700 |
Why?
| | tau Proteins | 1 | 2022 | 95 | 0.690 |
Why?
| | Synaptic Vesicles | 2 | 2015 | 41 | 0.690 |
Why?
| | Anesthesia | 3 | 2017 | 226 | 0.670 |
Why?
| | Propofol | 5 | 2017 | 86 | 0.660 |
Why?
| | Child Behavior | 2 | 2013 | 247 | 0.650 |
Why?
| | Neuronal Plasticity | 4 | 2017 | 301 | 0.650 |
Why?
| | Synaptic Transmission | 3 | 2018 | 295 | 0.630 |
Why?
| | Benzamides | 2 | 2018 | 213 | 0.620 |
Why?
| | Neuroprotective Agents | 2 | 2014 | 137 | 0.580 |
Why?
| | Inhibitory Postsynaptic Potentials | 2 | 2015 | 47 | 0.560 |
Why?
| | Testosterone | 1 | 2022 | 402 | 0.560 |
Why?
| | Macaca | 1 | 2017 | 64 | 0.540 |
Why?
| | Peripheral Nerves | 2 | 2014 | 70 | 0.520 |
Why?
| | Action Potentials | 2 | 2017 | 486 | 0.520 |
Why?
| | Neural Inhibition | 1 | 2018 | 177 | 0.510 |
Why?
| | Models, Animal | 1 | 2018 | 399 | 0.490 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2018 | 208 | 0.490 |
Why?
| | Thalamus | 2 | 2015 | 117 | 0.490 |
Why?
| | Axons | 2 | 2018 | 197 | 0.480 |
Why?
| | Ventral Thalamic Nuclei | 1 | 2015 | 5 | 0.470 |
Why?
| | Animals, Newborn | 10 | 2018 | 858 | 0.450 |
Why?
| | Synapses | 3 | 2017 | 424 | 0.440 |
Why?
| | Gasotransmitters | 1 | 2014 | 2 | 0.440 |
Why?
| | Pyridines | 1 | 2018 | 498 | 0.430 |
Why?
| | Carbon Monoxide | 1 | 2014 | 85 | 0.420 |
Why?
| | Pregnanolone | 1 | 2014 | 40 | 0.420 |
Why?
| | Neural Pathways | 1 | 2015 | 304 | 0.400 |
Why?
| | Nociception | 1 | 2013 | 17 | 0.400 |
Why?
| | Glycosylation | 1 | 2013 | 162 | 0.390 |
Why?
| | Cognition Disorders | 5 | 2013 | 509 | 0.390 |
Why?
| | Calcium Channels | 1 | 2013 | 156 | 0.390 |
Why?
| | Oxidation-Reduction | 2 | 2013 | 1079 | 0.380 |
Why?
| | Cognitive Dysfunction | 1 | 2017 | 390 | 0.380 |
Why?
| | Cerebral Cortex | 2 | 2015 | 447 | 0.370 |
Why?
| | Nitrous Oxide | 2 | 2015 | 33 | 0.350 |
Why?
| | Drug Delivery Systems | 1 | 2014 | 359 | 0.330 |
Why?
| | Neuropeptides | 3 | 2017 | 75 | 0.320 |
Why?
| | Neuroglia | 2 | 2016 | 173 | 0.320 |
Why?
| | Anesthesiology | 2 | 2017 | 116 | 0.320 |
Why?
| | Nociceptors | 3 | 2014 | 41 | 0.310 |
Why?
| | Cognition | 2 | 2021 | 1176 | 0.310 |
Why?
| | Patch-Clamp Techniques | 3 | 2015 | 290 | 0.300 |
Why?
| | Sciatic Neuropathy | 2 | 2015 | 31 | 0.300 |
Why?
| | Rats, Wistar | 6 | 2017 | 454 | 0.280 |
Why?
| | Mice | 9 | 2022 | 17848 | 0.260 |
Why?
| | Microscopy, Electron | 3 | 2015 | 438 | 0.260 |
Why?
| | Radiculopathy | 1 | 2017 | 36 | 0.260 |
Why?
| | Anesthetics, Intravenous | 3 | 2016 | 60 | 0.260 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2017 | 34 | 0.260 |
Why?
| | Connexins | 1 | 2017 | 49 | 0.250 |
Why?
| | Primates | 2 | 2021 | 138 | 0.250 |
Why?
| | Fas Ligand Protein | 1 | 2016 | 60 | 0.250 |
Why?
| | fas Receptor | 1 | 2016 | 97 | 0.240 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2017 | 155 | 0.240 |
Why?
| | Nerve Tissue Proteins | 3 | 2017 | 602 | 0.240 |
Why?
| | Cytoskeleton | 2 | 2011 | 193 | 0.240 |
Why?
| | Inflammasomes | 1 | 2017 | 133 | 0.240 |
Why?
| | Nerve Degeneration | 2 | 2015 | 48 | 0.220 |
Why?
| | Benzothiazoles | 2 | 2013 | 35 | 0.220 |
Why?
| | Phosphorylation | 3 | 2022 | 1770 | 0.210 |
Why?
| | Male | 17 | 2022 | 68216 | 0.210 |
Why?
| | Mitochondrial Dynamics | 1 | 2013 | 40 | 0.200 |
Why?
| | Midazolam | 3 | 2015 | 68 | 0.190 |
Why?
| | Muscimol | 1 | 2011 | 17 | 0.190 |
Why?
| | Infant | 5 | 2018 | 9565 | 0.180 |
Why?
| | Mice, Inbred C57BL | 4 | 2017 | 5812 | 0.180 |
Why?
| | Myelin Proteins | 1 | 2011 | 46 | 0.180 |
Why?
| | Peripheral Nerve Injuries | 2 | 2017 | 37 | 0.180 |
Why?
| | Nanoparticles | 1 | 2017 | 468 | 0.180 |
Why?
| | Female | 14 | 2022 | 73913 | 0.170 |
Why?
| | Mice, Knockout | 3 | 2017 | 3038 | 0.170 |
Why?
| | Periodicals as Topic | 1 | 2013 | 213 | 0.170 |
Why?
| | Gonadal Steroid Hormones | 1 | 2021 | 140 | 0.170 |
Why?
| | Brain-Derived Neurotrophic Factor | 3 | 2016 | 140 | 0.160 |
Why?
| | Up-Regulation | 2 | 2011 | 851 | 0.160 |
Why?
| | Behavior, Animal | 2 | 2014 | 512 | 0.160 |
Why?
| | Drug Synergism | 2 | 2015 | 371 | 0.160 |
Why?
| | Humans | 17 | 2018 | 138651 | 0.160 |
Why?
| | Biological Transport | 2 | 2015 | 403 | 0.160 |
Why?
| | Child, Preschool | 4 | 2018 | 11130 | 0.160 |
Why?
| | Astrocytes | 1 | 2011 | 215 | 0.150 |
Why?
| | Actins | 1 | 2011 | 420 | 0.150 |
Why?
| | Mitochondria | 3 | 2013 | 958 | 0.150 |
Why?
| | Proto-Oncogene Proteins c-fos | 2 | 2016 | 191 | 0.150 |
Why?
| | Social Behavior | 1 | 2021 | 291 | 0.140 |
Why?
| | Anesthetics, Dissociative | 1 | 2018 | 34 | 0.140 |
Why?
| | Organ Culture Techniques | 1 | 2018 | 157 | 0.140 |
Why?
| | Antioxidants | 3 | 2013 | 593 | 0.130 |
Why?
| | Cell Membrane | 2 | 2015 | 715 | 0.130 |
Why?
| | Stereotyped Behavior | 1 | 2017 | 22 | 0.130 |
Why?
| | Nerve Growth Factor | 2 | 2014 | 34 | 0.130 |
Why?
| | Apoptosis | 1 | 2016 | 2558 | 0.130 |
Why?
| | alpha-Synuclein | 1 | 2017 | 41 | 0.130 |
Why?
| | Ketamine | 1 | 2018 | 103 | 0.130 |
Why?
| | Dextroamphetamine | 1 | 2015 | 4 | 0.120 |
Why?
| | Hyperkinesis | 1 | 2015 | 17 | 0.120 |
Why?
| | Cell Death | 1 | 2017 | 375 | 0.120 |
Why?
| | Long-Term Potentiation | 1 | 2017 | 199 | 0.120 |
Why?
| | Pain Measurement | 2 | 2015 | 539 | 0.110 |
Why?
| | 4-Butyrolactone | 1 | 2015 | 22 | 0.110 |
Why?
| | Evoked Potentials, Somatosensory | 1 | 2015 | 35 | 0.110 |
Why?
| | X-Linked Inhibitor of Apoptosis Protein | 1 | 2014 | 11 | 0.110 |
Why?
| | United Kingdom | 2 | 2017 | 321 | 0.110 |
Why?
| | Neurogenesis | 2 | 2016 | 152 | 0.110 |
Why?
| | Oncogene Protein v-akt | 1 | 2014 | 24 | 0.110 |
Why?
| | Mibefradil | 1 | 2014 | 9 | 0.110 |
Why?
| | Electric Stimulation | 1 | 2015 | 276 | 0.110 |
Why?
| | Excitatory Postsynaptic Potentials | 1 | 2015 | 124 | 0.110 |
Why?
| | Receptors, GABA-A | 1 | 2015 | 140 | 0.110 |
Why?
| | Thioctic Acid | 1 | 2013 | 12 | 0.100 |
Why?
| | Child | 4 | 2017 | 21883 | 0.100 |
Why?
| | Central Nervous System Stimulants | 1 | 2015 | 176 | 0.100 |
Why?
| | Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2013 | 9 | 0.100 |
Why?
| | Neuraminidase | 1 | 2013 | 25 | 0.100 |
Why?
| | Infant, Newborn | 2 | 2018 | 6143 | 0.100 |
Why?
| | Asparagine | 1 | 2013 | 30 | 0.100 |
Why?
| | Mice, Obese | 1 | 2013 | 67 | 0.100 |
Why?
| | Piperidines | 1 | 2015 | 215 | 0.100 |
Why?
| | Sciatic Nerve | 1 | 2013 | 61 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2015 | 2045 | 0.100 |
Why?
| | In Vitro Techniques | 1 | 2015 | 1093 | 0.100 |
Why?
| | Nerve Fibers | 1 | 2013 | 98 | 0.100 |
Why?
| | Catalysis | 1 | 2013 | 318 | 0.100 |
Why?
| | Blotting, Western | 3 | 2013 | 1229 | 0.100 |
Why?
| | Metals | 1 | 2013 | 140 | 0.100 |
Why?
| | Cysteine | 1 | 2013 | 204 | 0.090 |
Why?
| | Protein Isoforms | 1 | 2013 | 396 | 0.090 |
Why?
| | Nerve Growth Factors | 1 | 2012 | 79 | 0.090 |
Why?
| | GTP Phosphohydrolases | 2 | 2013 | 94 | 0.090 |
Why?
| | Fetal Alcohol Spectrum Disorders | 1 | 2012 | 35 | 0.090 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2011 | 10 | 0.090 |
Why?
| | Posterior Horn Cells | 1 | 2011 | 10 | 0.090 |
Why?
| | Inhibitory Concentration 50 | 1 | 2011 | 89 | 0.090 |
Why?
| | Epigenesis, Genetic | 1 | 2016 | 647 | 0.090 |
Why?
| | Antibodies | 1 | 2013 | 407 | 0.090 |
Why?
| | Arachidonic Acid | 1 | 2011 | 125 | 0.090 |
Why?
| | Macaca mulatta | 1 | 2011 | 185 | 0.090 |
Why?
| | Transfection | 1 | 2013 | 942 | 0.090 |
Why?
| | Ion Channel Gating | 1 | 2011 | 91 | 0.090 |
Why?
| | Histones | 1 | 2016 | 637 | 0.080 |
Why?
| | Cells, Cultured | 2 | 2013 | 4175 | 0.080 |
Why?
| | Morphogenesis | 1 | 2011 | 170 | 0.080 |
Why?
| | HEK293 Cells | 1 | 2013 | 732 | 0.080 |
Why?
| | Epilepsy | 1 | 2015 | 337 | 0.080 |
Why?
| | GTP-Binding Proteins | 1 | 2011 | 151 | 0.080 |
Why?
| | Child Behavior Disorders | 1 | 2012 | 143 | 0.080 |
Why?
| | DNA Primers | 1 | 2011 | 509 | 0.080 |
Why?
| | Intellectual Disability | 1 | 2012 | 166 | 0.080 |
Why?
| | Recombinant Proteins | 1 | 2013 | 1358 | 0.080 |
Why?
| | Environment | 1 | 2011 | 339 | 0.080 |
Why?
| | Signal Transduction | 2 | 2014 | 5091 | 0.080 |
Why?
| | Anxiety | 1 | 2017 | 1066 | 0.080 |
Why?
| | Immunohistochemistry | 1 | 2013 | 1732 | 0.070 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1248 | 0.070 |
Why?
| | Nitric Oxide | 1 | 2013 | 894 | 0.070 |
Why?
| | Maze Learning | 2 | 2013 | 103 | 0.070 |
Why?
| | Skin | 1 | 2013 | 753 | 0.070 |
Why?
| | Molecular Targeted Therapy | 1 | 2011 | 414 | 0.070 |
Why?
| | Time Factors | 4 | 2017 | 6877 | 0.070 |
Why?
| | Base Sequence | 1 | 2011 | 2182 | 0.070 |
Why?
| | RNA, Messenger | 3 | 2016 | 2817 | 0.070 |
Why?
| | Motor Activity | 2 | 2017 | 715 | 0.070 |
Why?
| | Diabetic Nephropathies | 1 | 2011 | 301 | 0.070 |
Why?
| | Calcium | 1 | 2013 | 1185 | 0.070 |
Why?
| | Age Factors | 2 | 2012 | 3274 | 0.070 |
Why?
| | Analysis of Variance | 3 | 2015 | 1320 | 0.060 |
Why?
| | Caspase 8 | 1 | 2016 | 48 | 0.060 |
Why?
| | Caspase 9 | 1 | 2016 | 57 | 0.060 |
Why?
| | Neuroimmunomodulation | 1 | 2016 | 66 | 0.060 |
Why?
| | Caspase 1 | 1 | 2016 | 146 | 0.060 |
Why?
| | Reactive Oxygen Species | 2 | 2013 | 629 | 0.060 |
Why?
| | Bone Marrow Cells | 1 | 2017 | 325 | 0.060 |
Why?
| | Adjuvants, Anesthesia | 1 | 2015 | 13 | 0.060 |
Why?
| | Emergency Medical Services | 1 | 2011 | 562 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 238 | 0.060 |
Why?
| | Transcriptional Activation | 1 | 2017 | 376 | 0.060 |
Why?
| | Exploratory Behavior | 2 | 2017 | 91 | 0.050 |
Why?
| | Interleukin-1beta | 1 | 2016 | 376 | 0.050 |
Why?
| | Microglia | 1 | 2016 | 254 | 0.050 |
Why?
| | Austria | 1 | 2013 | 7 | 0.050 |
Why?
| | Pediatrics | 1 | 2011 | 1074 | 0.050 |
Why?
| | Subcellular Fractions | 1 | 2013 | 80 | 0.050 |
Why?
| | Dynamins | 1 | 2013 | 38 | 0.050 |
Why?
| | Catalase | 1 | 2013 | 134 | 0.050 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2013 | 193 | 0.050 |
Why?
| | Cytoplasm | 1 | 2013 | 270 | 0.050 |
Why?
| | Postoperative Complications | 1 | 2014 | 2701 | 0.050 |
Why?
| | GABA-A Receptor Agonists | 1 | 2011 | 17 | 0.050 |
Why?
| | Memory Disorders | 1 | 2013 | 175 | 0.050 |
Why?
| | Gene Expression | 1 | 2017 | 1494 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2017 | 875 | 0.040 |
Why?
| | Paxillin | 1 | 2011 | 12 | 0.040 |
Why?
| | Myosin Light Chains | 1 | 2011 | 28 | 0.040 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 353 | 0.040 |
Why?
| | Immunoprecipitation | 1 | 2011 | 155 | 0.040 |
Why?
| | Vimentin | 1 | 2011 | 53 | 0.040 |
Why?
| | Mitochondrial Proteins | 1 | 2013 | 258 | 0.040 |
Why?
| | Down-Regulation | 1 | 2013 | 638 | 0.040 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2011 | 102 | 0.040 |
Why?
| | Cell Division | 1 | 2011 | 791 | 0.040 |
Why?
| | Homeostasis | 1 | 2013 | 617 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2014 | 10938 | 0.040 |
Why?
| | Pregnancy | 1 | 2012 | 6836 | 0.040 |
Why?
| | Adaptation, Ocular | 1 | 2017 | 6 | 0.030 |
Why?
| | Risk Factors | 1 | 2012 | 10398 | 0.030 |
Why?
| | Synaptophysin | 1 | 2017 | 15 | 0.030 |
Why?
| | Sex Factors | 1 | 2013 | 2058 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2013 | 1153 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2017 | 4333 | 0.030 |
Why?
| | GAP-43 Protein | 1 | 2015 | 7 | 0.030 |
Why?
| | Nipecotic Acids | 1 | 2015 | 6 | 0.030 |
Why?
| | Microtubule-Associated Proteins | 1 | 2017 | 197 | 0.030 |
Why?
| | GABA Antagonists | 1 | 2015 | 35 | 0.030 |
Why?
| | Oximes | 1 | 2015 | 24 | 0.030 |
Why?
| | Cadherins | 1 | 2017 | 203 | 0.030 |
Why?
| | Receptors, Nerve Growth Factor | 1 | 2014 | 18 | 0.030 |
Why?
| | Receptors, Growth Factor | 1 | 2014 | 56 | 0.030 |
Why?
| | Streptozocin | 1 | 2014 | 23 | 0.030 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2014 | 198 | 0.020 |
Why?
| | Receptor, trkB | 1 | 2012 | 34 | 0.020 |
Why?
| | Salicylates | 1 | 2011 | 29 | 0.020 |
Why?
| | Dinoprost | 1 | 2011 | 46 | 0.020 |
Why?
| | Lipid Peroxidation | 1 | 2011 | 152 | 0.020 |
Why?
| | Hypothalamus | 1 | 2012 | 153 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 175 | 0.020 |
Why?
| | Caspase 3 | 1 | 2012 | 250 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2013 | 7683 | 0.020 |
Why?
| | Organometallic Compounds | 1 | 2011 | 112 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2012 | 317 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2011 | 769 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2012 | 445 | 0.020 |
Why?
| | Oxygen | 1 | 2011 | 967 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2602 | 0.010 |
Why?
| | Aged | 1 | 2013 | 24182 | 0.010 |
Why?
|
|
Todorovic's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|